NHS England Adds Three New Therapies To Cancer Drugs Fund List
Roche’s Trastuzumab emtansine, Bayer’s Radium-223 dichloride, and GlaxoSmithKline’s Dabrafenib have been added to the National Health Service’s (NHS) Cancer Drugs Fund list. NHS England released the update this week.
Source: Pharmaceutical Online News - Category: Pharmaceuticals Source Type: news
More News: Cancer | Cancer & Oncology | Health | Herceptin | National Health Service (NHS) | Pharmaceuticals | UK Health